These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
466 related items for PubMed ID: 29886590
21. Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases. Deveci MA, Paydaş S, Gönlüşen G, Özkan C, Biçer ÖS, Tekin M. Acta Orthop Traumatol Turc; 2017 Jan; 51(1):1-6. PubMed ID: 27784623 [Abstract] [Full Text] [Related]
22. Denosumab salvage therapy in a patient with a locally advanced and refractory sellar giant cell tumour of bone. Marques P, Appelman-Dijkstra NM, Gelderblom H, Kruit MC, van Furth WR, Pereira AM, Biermasz NR. Lancet Diabetes Endocrinol; 2020 Apr; 8(4):348. PubMed ID: 32059785 [No Abstract] [Full Text] [Related]
23. Giant cell tumor of bone under Denosumab treatment. Wendling D, Guillot X, Sondag M, Chaigneau L, Aubry S, Prati C. Joint Bone Spine; 2018 Jul; 85(4):491. PubMed ID: 28970075 [No Abstract] [Full Text] [Related]
24. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone. Zhang RZ, Ma TX, Qi DW, Zhao M, Hu T, Zhang GC. Orthop Surg; 2019 Dec; 11(6):1101-1108. PubMed ID: 31762217 [Abstract] [Full Text] [Related]
25. Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series. Girolami I, Mancini I, Simoni A, Baldi GG, Simi L, Campanacci D, Beltrami G, Scoccianti G, D'Arienzo A, Capanna R, Franchi A. J Clin Pathol; 2016 Mar; 69(3):240-7. PubMed ID: 26338802 [Abstract] [Full Text] [Related]
26. Denosumab treatment for giant-cell tumor of bone: a systematic review of the literature. Luengo-Alonso G, Mellado-Romero M, Shemesh S, Ramos-Pascua L, Pretell-Mazzini J. Arch Orthop Trauma Surg; 2019 Oct; 139(10):1339-1349. PubMed ID: 30877429 [Abstract] [Full Text] [Related]
27. Giant cell tumour of bone in the denosumab era. van der Heijden L, Dijkstra PDS, Blay JY, Gelderblom H. Eur J Cancer; 2017 May; 77():75-83. PubMed ID: 28365529 [Abstract] [Full Text] [Related]
28. A Translational Study of the Neoplastic Cells of Giant Cell Tumor of Bone Following Neoadjuvant Denosumab. Mak IW, Evaniew N, Popovic S, Tozer R, Ghert M. J Bone Joint Surg Am; 2014 Aug 06; 96(15):e127. PubMed ID: 25100780 [Abstract] [Full Text] [Related]
29. Response to Denosumab in 2 Children With Recurrent Giant Cell Tumor of the Bone With Pulmonary Metastasis. Reddy K, Ramirez L, Kukreja K, Venkatramani R. J Pediatr Hematol Oncol; 2021 Mar 01; 43(2):e215-e218. PubMed ID: 31714440 [Abstract] [Full Text] [Related]
30. Histopathological Features Of Denosumab Treated Giant Cell Tumours Of Bone "A Single Institutional Experience" At A Tertiary Care Center, Karachi. Ali SM, Yaqoob N, Aftab Aslam K, Tauseef S, Ahmed SK, Jilani SAA, Jamal S. J Ayub Med Coll Abbottabad; 2022 Mar 01; 34(1):73-81. PubMed ID: 35466631 [Abstract] [Full Text] [Related]
31. Utility of intraoperative magnetic resonance imaging for giant cell tumor of bone after denosumab treatment: a pilot study. Furuta T, Kubo T, Sakuda T, Saito T, Kurisu K, Muragaki Y, Adachi N. Acta Radiol; 2022 Feb 01; 63(2):176-181. PubMed ID: 33517664 [Abstract] [Full Text] [Related]
32. Diagnosis and monitoring denosumab therapy of giant cell tumors of bone: radiologic-pathologic correlation. Lejoly M, Van Den Berghe T, Creytens D, Huysse W, Lapeire L, Sys G, Verstraete K. Skeletal Radiol; 2024 Feb 01; 53(2):353-364. PubMed ID: 37515643 [Abstract] [Full Text] [Related]
33. Denosumab-treated Giant Cell Tumors of Bone: A Clinicopathologic Analysis of 35 Cases From the French Group of Bone Pathology. Treffel M, Lardenois E, Larousserie F, Karanian M, Gomez-Brouchet A, Bouvier C, Le Loarer F, Aubert S, de Pinieux G, Audard V, Rios M, Sirveaux F, Vignaud JM, Gauchotte G, Marie B. Am J Surg Pathol; 2020 Jan 01; 44(1):1-10. PubMed ID: 31651524 [Abstract] [Full Text] [Related]
34. Ultra-Short Course of Neo-Adjuvant Denosumab for Nerve-Sparing Surgery for Giant Cell Tumor of Bone in Sacrum. Liang H, Liu X, Yang Y, Guo W, Yang R, Tang X, Yan T, Li Y, Tang S, Li D, Qu H, Dong S, Ji T, Du Z, Zang J. Spine (Phila Pa 1976); 2022 May 01; 47(9):691-701. PubMed ID: 34961753 [Abstract] [Full Text] [Related]
35. Interest of Denosumab for the Treatment of Giant-cells Tumors and Aneurysmal Bone Cysts of the Spine. About Nine Cases. Dubory A, Missenard G, Domont J, Court C. Spine (Phila Pa 1976); 2016 Jun 01; 41(11):E654-E660. PubMed ID: 27244112 [Abstract] [Full Text] [Related]
36. Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone. Rutkowski P, Ferrari S, Grimer RJ, Stalley PD, Dijkstra SP, Pienkowski A, Vaz G, Wunder JS, Seeger LL, Feng A, Roberts ZJ, Bach BA. Ann Surg Oncol; 2015 Sep 01; 22(9):2860-8. PubMed ID: 26033180 [Abstract] [Full Text] [Related]
37. Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone. Engellau J, Seeger L, Grimer R, Henshaw R, Gelderblom H, Choy E, Chawla S, Reichardt P, O'Neal M, Feng A, Jacobs I, Roberts ZJ, Braun A, Bach BA. World J Surg Oncol; 2018 Sep 19; 16(1):191. PubMed ID: 30231890 [Abstract] [Full Text] [Related]
38. Recurrent giant cell tumour of the maxillary sinus and pterygoid process treated with denosumab. Rosa D, Dias RB, Salvador JC, Borges A. BMJ Case Rep; 2018 Sep 08; 2018():. PubMed ID: 30196254 [Abstract] [Full Text] [Related]
39. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience. Agarwal MG, Gundavda MK, Gupta R, Reddy R. Clin Orthop Relat Res; 2018 Sep 08; 476(9):1773-1782. PubMed ID: 30794215 [Abstract] [Full Text] [Related]
40. The role of Denosumab in joint preservation for patients with giant cell tumour of bone. Perrin DL, Visgauss JD, Wilson DA, Griffin AM, Abdul Razak AR, Ferguson PC, Wunder JS. Bone Joint J; 2021 Jan 08; 103-B(1):184-191. PubMed ID: 33380180 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]